Sigal SMS GmbH, Germany
SIGAL SMS was founded by Dr. Helena Sigal, who started her career in clinical research more than 15 years ago as an investigator. In 2008, Helena was appointed as Director Clinical Operations, responsible for leading 9 German research sites and established further sites across Europe. Following acquisition by Synexus, Helena continued growth in Germany, leading a team of 70 clinical researchers.
Five years ago, Helena established her own SMO, determined to share her knowledge and expertise with private physicians across Germany to establish a network of fully supported clinical research sites alongside successful medical practices. Today, Helena Sigal leads a young, successful and highly motivated team, which works proactively, creatively and solution-oriented which she is very proud of. The network currently includes around 30 study sites in Germany and new ones are constantly being added.